Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange. - Wikidata - awgldk - TriplyDB

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

http://www.wikidata.org/entity/Q33375264

about

The potential utility of B cell-directed biologic therapy in autoimmune diseases.Rituximab in the treatment of autoimmune haematological disorders.Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single-centre experience.Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.Rituximab in indolent lymphomas.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.

P2860

Q33377109-93B6C855-7B0E-442F-A105-66CB6E6FDF14 Q33378854-9E8717D3-9FC2-4A21-92BF-4CAD8B32DF2F Q33379313-FEC7D4E6-43C4-4260-B2CE-EEE07447F219 Q33391086-28CDCFFB-F232-4B7E-8029-7AAB9E3F04E6 Q33412347-EF03FD11-A579-44AF-8106-F9135DEC6963 Q33425754-3150A9FC-CB7C-41BF-8279-CE33BB66A081 Q33764062-3780ACDF-056C-4CB8-8028-E1C204E60E99 Q37843939-676B0A8B-FDAA-4409-8628-FE3FC9FC658D

P2860

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

http://www.wikidata.org/entity/Q33375264

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@ast

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@en

type

label

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@ast

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@en

prefLabel

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@ast

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@en

P1433

Q33375264-479FEF05-F5E7-4F9D-8F94-D93CE783900A

P1476

Q33375264-A15D96BF-43DF-4782-9D62-157D29CE71AE

P2093

Q33375264-29F10AE6-8010-4384-B718-DA8259098365

Q33375264-44B581B7-5283-4A47-AE7E-0DDD45573E36

Q33375264-4B068DAE-29D4-4E39-BE7E-1C627C7B7D8A

Q33375264-5759E99D-9258-4B23-905D-F679DC3DD898

Q33375264-57F7669A-8579-420B-9C36-B7D76B580087

Q33375264-77B822D9-029E-4265-8A04-E2C8305A9CAF

P2860

Q33375264-1F37D176-151F-4C91-9448-AF092C59F6CC

Q33375264-283295BC-3F62-4F00-9C81-07E77B8A04E2

Q33375264-490EE0CE-695F-45B4-8AA1-BE3A92330AF8

Q33375264-52C10143-B59C-4E01-A693-17523CFB095C

Q33375264-7249FAB9-2D76-429E-9659-38AE310D82C9

Q33375264-879ADF04-007F-412E-BEF1-B3B0F2D41DFA

Q33375264-9A7AAE8B-50BF-4A29-846C-C83E22B737F9

Q33375264-B254242F-C39B-40DD-B4D5-F9544DAA1D4D

Q33375264-BB38FF2D-D8B7-4937-8463-DBA577CCB068

Q33375264-D0CEB5B0-8FA8-4F4A-B672-4F4F9C1E9421

P304

Q33375264-7E3FA841-E964-4438-B891-54AA58DE5F07

P31

Q33375264-32A42E50-018C-4BC3-815B-AB7826D385A4

P356

Q33375264-47FF3EFD-D6F9-4522-9EF5-53A0D875252D

P433

Q33375264-D587C0BC-8DDC-4AC5-B2C7-C2A07B057164

P478

Q33375264-3C77A7E7-B2FD-4206-8AFA-5E1105AC125A

P577

Q33375264-CB06D858-8DC7-4829-891F-5F18C7FC09D7

P698

Q33375264-70E425A9-6E54-4058-866C-E82EE9AAFA8D

P921

Q33375264-378C799A-4DB1-400F-BD29-FCE2DA218D0F

Q33375264-AB7376FB-354A-46C3-A671-860C026E4E2B

P356

J.1445-5994.2007.01338.X

P1433

Internal Medicine Journal

P1476

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.

@en

P2093

Becker G

http://www.w3.org/2001/XMLSchema#string

Branley P

http://www.w3.org/2001/XMLSchema#string

Carroll R

http://www.w3.org/2001/XMLSchema#string

Chow KV

http://www.w3.org/2001/XMLSchema#string

Hogan C

http://www.w3.org/2001/XMLSchema#string

Nicholls K

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

P304

329-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-5994.2007.01338.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17504282

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia